Literature DB >> 15527546

Anti-TNF-alpha therapy for chronic inflammation: reconsidering pentoxifylline as an alternative to therapeutic protein drugs.

M W Whitehouse1.   

Abstract

Pentoxifylline is a useful inhibitor of TNF-alpha production, thus resembling anti-inflammatory corticosteroids. The combination of pentoxifylline with Lyprinol is an effective treatment for chronic inflammation in rats, in this respect mimicking low dose prednisone with Lyprinol.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15527546     DOI： 10.1163/1568560042342293

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN： 0925-4692            Impact factor:   4.473


  5 in total

1.  Proposal to use pentoxifylline and Lyprinol therapy for chronic inflammatory diseases.

Authors:  S H Ferreira
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

Review 2.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

Review 3.  Nutritional and anti-inflammatory interventions in chronic heart failure.

Authors:  Kamyar Kalantar-Zadeh; Stefan D Anker; Tamara B Horwich; Gregg C Fonarow
Journal:  Am J Cardiol       Date:  2008-06-02       Impact factor: 2.778

Review 4.  Perna canaliculus and the Intestinal Microbiome.

Authors:  Emma Tali Saltzman; Michael Thomsen; Sean Hall; Luis Vitetta
Journal:  Mar Drugs       Date:  2017-06-30       Impact factor: 5.118

5.  Lyprinol-is it a useful anti-inflammatory agent?

Authors:  Sheila A Doggrell
Journal:  Evid Based Complement Alternat Med       Date:  2011-08-11       Impact factor: 2.629
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.